Postoperative Pain Management Market Size, Future Forecast, Key Manufactures And Industrial Opportunities To 2026
Postoperative pain
includes all type of acute pain that occurs due to injuries and can
resolve in appropriate healing period. Such pain often responds to
analgesic medication and treatment of the precipitating cause.
Postoperative pain can also cause cardiovascular, respiratory,
endocrine, metabolic etc. The aim of any postoperative pain treatment
is to mobilize the patient as early as possible. It allows the
patient to drink and eat as early as possible and to be able to deep
breathe and cough. If patients are not given proper postoperative
pain treatment, they can have risk of cardiac problems, chest
infections, depression, wound increased infection rate and hypoxia.
Postoperative pain treatment evolved with different understanding of
how drugs affect in our body when used in combinations.
Opioids and
Non-steroidal anti-inflammatory drugs are expected to contribute
major share in terms of value to the overall postoperative pain
market. Opioids act as a substance that acts on the opioid receptor
to produce morphine like effects. They are most often used to relieve
main. Non-steroidal anti-inflammatory drugs are used to treat pain,
inflammation and fever.
Request
Sample Copy Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/154
Global
Postoperative Pain Management Market Taxonomy
On the basis of
product type, the global market is classified as follows:
-
Opioids
-
Fentanyl
-
Morphine
-
Meperidine
-
Others
-
-
Non-steroidal anti-inflammatory drugs
-
Paracetamol (acetaminophen)
-
Ibuprofen
-
Ketorolac tromethamine
-
-
Cyclooxygenase-2-selective inhibitors
-
Celecoxib
-
Etoricoxib
-
Rofecoxib
-
-
Glucocorticods
-
Local anesthetics
-
Antidepressants
-
Others
On the basis of type
of pain, the global market is classified as follows:
-
Neuropathic Pain
-
Nociceptive Pain
-
Visceral Pain
-
Somatic Pain
-
Others
-
Prevalent
Scenarios in Postoperative Pain Management Market
Increasing number of
surgical procedure is expected to act as a value-driver to the global
postoperative pain management market. As per the World Bank, in the
U.S. there were 30,537 number of surgical procedures performed in
2012. As per National Center for Health Statistics, of overall
surgical procedures half of the procedure requires postoperative pain
medication which provides high opportunity for manufacturers. As per
Centers for Disease Control and Prevention (CDC), every year there
are around 41 million visits in emergency department due to trauma.
Around 450,000 burns require medical attention annually. Increase in
trauma cases to act as a fuel to the overall growth of postoperative
pain management market. Some postoperative pain drugs include side
effects. Despite the many advancement in postoperative pain
management, opioids are still considered as the mainstay pain therapy
in many settings. All opioids have significant side effects that are
limiting its use. One of the major side-effects associated with the
use of opioid is respiratory depression.
Highly
Fragmented Market
The global
postoperative pain management market is highly fragmented, owing to
the participation of many established and emerging players. Major
players involved in the market are Bayer AG, DURECT Corporation,
Pfizer Inc., BTG International Ltd, Novartis AG, A.P. Pharma, Inc.,
among others.
Click To
Read More On Postoperative
Pain Management Market
About
Coherent Market Insights:
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Comments
Post a Comment